J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
India · Delayed Price · Currency is INR 2,412.25
-93.35 (-3.73%)
At close: Jul 16, 2026
BOM:506943 Market Cap
BOM:506943 has a market cap or net worth of 387.31 billion as of July 27, 2026. Its market cap has increased by 50.47% in one year.
Market Cap
387.31B
Enterprise Value
375.13B
Revenue
41.48B
Ranking
n/a
PE Ratio
54.27
Stock Price
2,412.25
ChartMarket Cap Chart
Since December 11, 2001, BOM:506943's market cap has increased from 408.70M to 387.31B, an increase of 94,665.46%. That is a compound annual growth rate of 32.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 387.31B | 35.81% |
| Dec 31, 2025 | 285.18B | -0.62% |
| Dec 31, 2024 | 286.94B | 13.93% |
| Dec 29, 2023 | 251.85B | 67.53% |
| Dec 30, 2022 | 150.33B | 9.43% |
| Dec 31, 2021 | 137.38B | 74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lupin | 1.08T |
| Dr. Reddy's Laboratories | 960.10B |
| Abbott India | 595.05B |
| GlaxoSmithKline Pharmaceuticals | 425.76B |
| Rubicon Research | 250.45B |
| Granules India | 206.58B |
| AstraZeneca Pharma India | 200.00B |
| Caplin Point Laboratories | 187.34B |